FLOATING-BIOADHESIVE MATRIX TABLETS OF HYDRALAZINE HCL MADE OF CASHEW GUM AND HPMC K4M
Objective: The objective of this paper was to prepare and evaluate floating-bioadhesive cashew gum-hydroxypropyl methylcellulose (HPMC K4M) matrix tablets for the gastro-retentive release of hydralazine HCl.
Methods: The cashew gum-HPMC K4M matrix tablets of hydralazine HCl were prepared by direct compression method with the incorporation of sodium bicarbonate and citric acid as effervescent agents. Drug contents, weight variations, hardness, friability, in vitro swelling, in vitro floatation, ex vivo mucoadhesion and in vitro drug release of these matrix tablets were evaluated.
Results: Drug contents, weight variations, hardness and friability of these matrix tablets were within the compendia limits. These tablets were floated well in vitro over 12 h in simulated gastric fluid (SGF, pH 1.2) with minimum lag time. The ex vivo adhesion of these matrix tablets with goat intestinal mucosa exhibited good bioadhesion in a wash off test. All these cashew gum-HPMC K4M floating-bioadhesive matrix tablets of hydralazine HCl showed in vitro sustained releases of hydralazine HCl over 12 h in SGF, pH 1.2. The in vitro hydralazine HCl followed Korsmeyer-Peppas kinetic model and anomalous (non-Fickian) diffusion mechanism. The drug-polymer compatibility analysis by FTIR spectroscopy indicated the absence of any drug-polymer interaction within this cashew gum-HPMC K4M floating-bioadhesive matrix tablets of hydralazine HCl.
Conclusion: The results clearly indicate a promising potential of the use of cashew gum as matrix forming a material with HPMC K4M to prepare matrix tablets for gastro retentive delivery of hydralazine HCl through the combined approach of floatation and bioadhesion to reduce the dosing rate with better patient compliances.
2. Malakar J, Dutta P, Purokayastha SD, Dey S, Nayak AK. Floating capsules containing alginate-based beads of salbutamol sulfate: in vitro-in vivo evaluations. Int J Biol Macromol 2014;64:181-9.
3. Jadhav KR, Pawar AY, Talele GS. Development of gastro retentive optimized once a day floating and/or bioadhesive tablet of alfuzosin. Asian J Pharm Clin Res 2013;6:225-30.
4. Nayak AK, Maji R, Das B. Gastroretentive drug delivery systems: a review. Asian J Pharm Clin Res 2010;3:2-10.
5. Nayak AK, Malakar J, Sen KK. Gastroretentive drug delivery technologies: current approaches and future potential. J Pharm Educ Res 2010;1:1-12.
6. Jain SK, Agrawal GP, Jain NK. Floating microspheres as drug delivery system: newer approaches. Curr Drug Delivery 2008;5:220-3.
7. Nayak AK, Malakar J. Formulation and in vitro evaluation of a gastroretentive hydrodynamically balanced system for ciprofloxacin HCl. J Pharm Educ Res 2010;1:65-8.
8. Verma A, Dubey J, Verma N, Nayak AK. Chitosan-hydroxypropyl methylcellulose matrices as carriers for hydrodynamically balanced capsules of moxifloxacin HCl. Curr Drug Delivery 2017;14:83-90.
9. Nayak AK, Malakar J. Formulation and in vitro evaluation of a hydrodynamically balanced system for theophylline delivery. J Basic Clin Pharm 2011;2:133-7.
10. Nayak AK, Das B, Maji R. Gastroretentive hydrodynamically balanced system of ofloxacin: formulation and in vitro evaluation. Saudi Pharm J 2013;21:113-7.
11. Nayak AK, Pal D, Malakar J. Development, optimization and evaluation of emulsion-gelled floating beads using natural polysaccharide-blend for controlled drug release. Polym Eng Sci 2013;53:338-50.
12. Malakar J, Nayak AK, Pal D. Development of cloxacillin loaded multiple-unit alginate-based floating system by emulsionâ€“gelation method. Int J Biol Macromol 2012;50:138-47.
13. Malakar J, Nayak AK. Formulation and statistical optimization of the multiple-unit ibuprofen-loaded buoyant system using 23-factorial design. Chem Eng Res Des 2012;9:1834-46.
14. Agarwal S, Zamil F, Singh L, Saxena A. Formulation and evaluation of floating beads of diltiazem HCl. Int J Curr Pharm Res 2016;8:38-42.
15. Rao MRP, Sonar GS, Mandsaurwale RR, Vanshiv SD. Evaluation of effervescent floating matrix tablet formulations of salbutamol sulfate using full factorial design. Asian J Pharm 2009;3:43-9.
16. Someshwar K, Chithaluru K, Ramarao T, Kumar KKK. Formulation and evaluation of effervescent floating tablets of tizanidine hydrochloride. Acta Pharm 2011;61:217â€“26.
17. Preetha P, Rao AS, Sadhana G. Formulation and evaluation of floating effervescent tablets of metoprolol succinate. Int J Appl Pharm 2014;6:13-6.
18. Shah HP, Prajapati ST, Patel CN. Gastroretentive drug delivery systems: From conception to commercial success. J Crit Rev 2017;4:10-21.
19. Bera H, Kandukuri SG, Nayak AK, Boddupalli S. Alginate-sterculia gum gel-coated oil-entrapped alginate beads for gastro retentive risperidone delivery Carbohydr Polym 2015;120:74-84.
20. Bera H, Boddupalli S, Nandikonda S, Kumar S, Nayak AK. Alginate gel-coated oil-entrapped alginateâ€“tamarind gumâ€“magnesium stearate buoyant beads of risperidone. Int J Biol Macromol 2015;78:102-11.
21. Guru PR, Nayak AK, Sahu RK. Oil-entrapped sterculia gum-alginate buoyant systems of aceclofenac: development and in vitro evaluation. Colloids Surf B 2013;104:268-75.
22. Nayak AK, Pal D. Trigonella foenum-graecum L. seed mucilage-gellan mucoadhesive beads for controlled release of metformin HCl. Carbohydr Polym 2014;107:31-40.
23. Sinha P, Ubaidulla U, Nayak AK. Okra (Hibiscus esculentus) gum-alginate blend mucoadhesive beads for controlled glibenclamide release. Int J Biol Macromol 2015;72:1069-75.
24. Nayak AK, Pal D, Santra K. Ispaghula mucilage-gellan mucoadhesive beads of metformin HCl: development by response surface methodology. Carbohydr Polym 2014;107:41-50.
25. Nayak AK, Pal D, Santra K. Development of pectinate-ispagula mucilage mucoadhesive beads of metformin HCl by central composite design. Int J Biol Macromol 2014;66:203-21.
26. Nayak AK, Pal D, Santra K. Artocarpus heterophyllus L. seed starch-blended gellan gum mucoadhesive beads of metformin HCl. Int J Biol Macromol 2014;65:329-39.
27. Nayak AK, Pal D. Blends of jackfruit seed starch-pectin in the development of mucoadhesive beads containing metformin HCl. Int J Biol Macromol 2013;62:137-45.
28. Nayak AK, Pal D, Pradhan J, Hasnain MS. Fenugreek seed mucilage-alginate mucoadhesive beads of metformin HCl: design, optimization and evaluation. Int J Biol Macromol 2013;54:144-54.
29. Nayak AK, Pal D. Formulation optimization of jackfruit seed starch-alginate mucoadhesive beads of metformin HCl. Int J Biol Macromol 2013;59:264-72.
30. Bera H, Boddupalli S, Nayak AK. Mucoadhesive-floating zinc-pectinate-sterculia gum interpenetrating polymer network beads encapsulating ziprasidone HCl. Carbohydr Polym 2015;131:108-18.
31. Malakar J, Nayak AK. Floating bioadhesive matrix tablets of ondansetron HCl: Optimization of hydrophilic polymer blends. Asian J Pharm 2013;7:174-83.
32. Belgamwar VS, Surana SJ. Floating bioadhesive drug delivery system using novel effervescent agents. Asian J Pharm 2009;3:156-60.
33. Bandameedi R, Pandiyan PS. Formulation and evaluation of gastro retentive floating bioadhesive tablets of hydrochlorothiazide. Asian J Pharm Clin Res 2017;10:150-5.
34. Gowthamarajan K, Phani Kumar GK, Gaikward NB, Suresh B. Preliminary study of Anacardium occidentale gum as a binder in the formulation of paracetamol tablets. Carbohydr Polym 2011;83:506-11.
35. De Paula RCM, Rodrigues JF. Composition and rheological properties of cashew tree gum, the exudate polysaccharide from Anacardium occidentale L. Carbohydr Polym 1995;26:177-81.
36. Ofori-kwakye K, Asantewaa Y, Kipo SI. Physicochemical and binding properties of cashew gum in metronidazole tablet formulations. Int J Pharm Pharmaceut Sci 2010;2:105-9.
37. Kumar R, Patil MB, Patil SR, Paschapur MS. Evaluation of Anacardium occidentale gum as a gelling agent in aceclofenac gel. Int J PharmTech Res 2009;1:695-704.
38. Azeez OS. Production of gum from cashew gum tree latex. Leonardo Electron J Pract Technol 2005;7:17-22.
39. Okoye EI, Onyekweli AO, Ohwoavworhua FO, Kunle OO. Comparative study of some mechanical and release properties of paracetamol tablets formulated with cashew tree gum, povidone and gelatin as binders. Afr J Biotechnol 2009;8:3970-3.
40. Ganesh GNK, Sureshkumar R, Jawahar N, Senthil V, Venkatesh DN, Srinivas MS. Preparation and evaluation of sustained release matrix tablet of diclofenac sodium using polymer. J Pharm Sci Res 2010;2:360-8.
41. Paula HCB, de Oliveira EF, Abreu FOMS, de Paula RCM. Alginate/cashew gum floating bead as a matrix for larvicide release. Mater Sci Eng C 2012;C32:1421-7.
42. Oates JA, Brown NJ. Antihypertensive Agents and the Drug Therapy of Hypertension, In: Hardman G, Limbird LE. Goodman and Gilmanâ€™s The Pharmacological Basis of Therapeutics. 10th ed. McGraw Hill Medical Publishing Division, New York; 2001. p. 871â€“900.Singh B, Pahuja S, Kapil R, Ahuja N. Formulation development of oral controlled release tablets of hydralazine. Optimisation of drug release and bioadhesive characteristics. Acta Pharm 2009;59:1â€“13.
43. Uner M, Celebi B. Design of hydralazine hydrochloride matrix tablets based on various polymers and lipids. Indian J Pharm Educ Res 2012;46:75-87.
44. Malakar J, Das K, Nayak AK. Statistical optimisation in formulation development of in situ cross-linked matrix tablets for sustained salbutamol sulfate release. Polym Med 2014;44:221â€“30.
45. US Pharmacopoeia National Formulary, USP 23/NF 18, United States Pharmacopoeia Convention Inc., Rockville, MD; 2000.
46. The Indian Pharmacopoeia, The Controller of Publications. Vol. 1. Ministry of Health, Govt. of India, New Delhi; 1996. p. 190.
47. British Pharmacopoeia, The Pharmaceutical Press. Vol. 1. Her Majestyâ€™s Office, London; 1998. p. 1296.
48. Allen LV, Popovich NG, Ansel HC. Anselâ€™s pharmaceutical dosage forms and drug delivery systems. 8th edition. Lippincott Williams and Wilkins, Philadelphia; 2004.
49. Nayak AK, Pal D, Santra K. Swelling and drug release behaviour of metformin HCl-loaded tamarind seed polysaccharide-alginate beads. Int J Biol Macromol 2016;82:1023-7.
50. Siepmann J, Peppas NA. Modelling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Delivery Rev 2001;48:139â€“57.